AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33303576 — intervention group
Group type: EXPERIMENTAL
Intervention: EPHA mutation (EPHAmut)
Number of subjects: 79
Study 33303576 — intervention group
Group type: EXPERIMENTAL
Intervention: EPHA mutation (EPHAmut) in cohort 1
Number of subjects: 79
Study 33303576 — intervention group
Group type: EXPERIMENTAL
Intervention: EPHA mutation (EPHAmut) in cohort 2
Number of subjects: 79
Study 36168844 — intervention group
Group type: EXPERIMENTAL
Intervention: Abemaciclib + fulvestrant
Number of subjects: 212
Study 36168844 — intervention group
Group type: COMPARATOR
Intervention: Placebo + fulvestrant
Number of subjects: 212
Study 34000886 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care plus intervention (palliative rehabilitation) - 12-week intervention with two mandatory consultations and interdisciplinary group program
Number of subjects: 288
Study 34000886 — intervention group
Group type: COMPARATOR
Intervention: Standard oncology care (control group)
Number of subjects: 288
Study 32880602 — intervention group
Group type: EXPERIMENTAL
Intervention: Eribulin plus Pembrolizumab (Eribulin 1.4 mg/m2 IV on days 1 and 8 plus Pembrolizumab 200 mg/m2 IV on day 1 of a 21-day cycle)
Number of subjects: 88
Study 32880602 — intervention group
Group type: COMPARATOR
Intervention: Eribulin alone
Number of subjects: 88
Study 32880602 — intervention group
Group type: EXPERIMENTAL
Intervention: Crossover treatment with Pembrolizumab after progression on Eribulin monotherapy
Number of subjects: 88
Study 32880602 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Eribulin with Pembrolizumab and Eribulin alone)
Number of subjects: 88
Study 33510373 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-body dynamic exercise (walking at 65-70% of HRmax)
Number of subjects: 26
Study 33510373 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic upper-body exercise (three 5 min workloads, 56-80% of HRmax)
Number of subjects: 26
Study 33510373 — intervention group
Group type: COMPARATOR
Intervention: Static upper-body exercise (five 1.5 min work cycles, 10-30% of maximal voluntary contraction)
Number of subjects: 26
Study 32783267 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.7% fumaric acid treatment on fiber post surface and 0.7% fumaric acid treatment on dentin surface
Number of subjects: 60
Study 32783267 — intervention group
Group type: EXPERIMENTAL
Intervention: 9% hydrofluoric acid treatment on fiber post surface and 0.7% fumaric acid treatment on dentin surface
Number of subjects: 60
Study 32783267 — intervention group
Group type: COMPARATOR
Intervention: Control (no conditioning) on dentin surface and 9% hydrofluoric acid treatment on fiber post surface
Number of subjects: 60
Study 32783267 — intervention group
Group type: EXPERIMENTAL
Intervention: 17% EDTA treatment on dentin surface and 9% hydrofluoric acid treatment on fiber post surface
Number of subjects: 60
Study 32783267 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.7% fumaric acid treatment on dentin surface and 9% hydrofluoric acid treatment on fiber post surface
Number of subjects: 60
Study 33610736 — intervention group
Group type: EXPERIMENTAL
Intervention: SRP + PDT
Number of subjects: 84
Study 33610736 — intervention group
Group type: COMPARATOR
Intervention: SRP only
Number of subjects: 84
Study 34182194 — intervention group
Group type: EXPERIMENTAL
Intervention: OT+XNJ (i.v. 20 ml/daily)
Number of subjects: 80
Study 34182194 — intervention group
Group type: EXPERIMENTAL
Intervention: OT+low dose-YB (oral, 1,000 mg/day)
Number of subjects: 80
Study 34182194 — intervention group
Group type: EXPERIMENTAL
Intervention: OT+high dose-YB (oral, 2,000 mg/day)
Number of subjects: 80
Study 34182194 — intervention group
Group type: COMPARATOR
Intervention: OT
Number of subjects: 80
Study 34182194 — intervention group
Group type: EXPERIMENTAL
Intervention: XNJ, l-YB, h-YB
Number of subjects: 80
Study 35380346 — intervention group
Group type: EXPERIMENTAL
Intervention: Specialized medical home intervention
Number of subjects: 331
Study 35380346 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 331
Study 33972573 — intervention group
Group type: EXPERIMENTAL
Intervention: PT150 (900 mg/day) administered orally for five days
Number of subjects: 11
Study 33972573 — intervention group
Group type: COMPARATOR
Intervention: Placebo (1% ethanol) beverage
Number of subjects: 11
Study 35220954 — intervention group
Group type: EXPERIMENTAL
Intervention: High flow oxygen supply
Number of subjects: 0
Study 35220954 — intervention group
Group type: COMPARATOR
Intervention: Standard oxygen
Number of subjects: 0
Study 33657674 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based rehabilitation (GBR)
Number of subjects: 80
Study 33657674 — intervention group
Group type: COMPARATOR
Intervention: Individual-based rehabilitation (IBR)
Number of subjects: 80
Study 32776907 — intervention group
Group type: EXPERIMENTAL
Intervention: supplemented Er‐xian decoction combined with acupoint application
Number of subjects: 80
Study 32776907 — intervention group
Group type: COMPARATOR
Intervention: Kuntai capsule
Number of subjects: 80
Study 34664772 — intervention group
Group type: EXPERIMENTAL
Intervention: Dronedarone
Number of subjects: 0
Study 34664772 — intervention group
Group type: COMPARATOR
Intervention: Placebo/Standard of Care
Number of subjects: 0
Study 34915594 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face delivery/conventional reduced energy diet (n = 36)
Number of subjects: 110
Study 34915594 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote delivery (RD)/conventional reduced energy diet (n = 39)
Number of subjects: 110
Study 34915594 — intervention group
Group type: EXPERIMENTAL
Intervention: RD/reduced energy enhanced stop light diet (eSLD) (n = 35)
Number of subjects: 110
Study 34915594 — intervention group
Group type: COMPARATOR
Intervention: All groups combined
Number of subjects: 110
Study 32187070 — intervention group
Group type: EXPERIMENTAL
Intervention: Millard repair
Number of subjects: 50
Study 32187070 — intervention group
Group type: EXPERIMENTAL
Intervention: Onizuka repair
Number of subjects: 50
Study 32187070 — intervention group
Group type: EXPERIMENTAL
Intervention: Fisher repair
Number of subjects: 50
Study 32187070 — intervention group
Group type: EXPERIMENTAL
Intervention: Millard repair (cut-as-you-go policy)
Number of subjects: 50
Study 32156255 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH)
Number of subjects: 221
Study 32156255 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized dosage of MPH
Number of subjects: 221
Study 32156255 — intervention group
Group type: EXPERIMENTAL
Intervention: MPH over treatment period
Number of subjects: 221
Study 35747337 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI)
Number of subjects: 45
Study 35747337 — intervention group
Group type: COMPARATOR
Intervention: Supportive counselling (SC)
Number of subjects: 45
Study 33305631 — intervention group
Group type: EXPERIMENTAL
Intervention: OLNP-06, 200 mg twice daily
Number of subjects: 50
Study 33305631 — intervention group
Group type: COMPARATOR
Intervention: Placebo, 200 mg twice daily
Number of subjects: 50
Study 33210806 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage (15-minute massage on calf muscles)
Number of subjects: 78
Study 33210806 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold Water Immersion (CWI) (15 ± 1°C for 15 minutes)
Number of subjects: 78
Study 33210806 — intervention group
Group type: COMPARATOR
Intervention: Passive Rest
Number of subjects: 78
Study 35410182 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviour change communication intervention on hypertension and diabetes
Number of subjects: 0
Study 32701529 — intervention group
Group type: EXPERIMENTAL
Intervention: TXA with microneedling
Number of subjects: 56
Study 32701529 — intervention group
Group type: COMPARATOR
Intervention: Intraderma injection of TXA
Number of subjects: 56
Study 34271197 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosexual education through e-learning for 8 weeks
Number of subjects: 38
Study 33260939 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommended behavior group (RB group) - drank 200 mL of water every 2 h
Number of subjects: 92
Study 33260939 — intervention group
Group type: EXPERIMENTAL
Intervention: Half amount group (HA group) - drank 100 mL of water every 2 h
Number of subjects: 92
Study 33260939 — intervention group
Group type: EXPERIMENTAL
Intervention: High frequency group (HF group) - drank 110 mL of water every 1 h
Number of subjects: 92
Study 36268614 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based Intensive Nutrition Therapy (HINT)
Number of subjects: 100
Study 36268614 — intervention group
Group type: COMPARATOR
Intervention: Standard Medical Therapy (SMT)
Number of subjects: 100
Study 32856209 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone 16 mg twice daily for 7 days
Number of subjects: 50
Study 32856209 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 32534981 — intervention group
Group type: EXPERIMENTAL
Intervention: Advance care directive present
Number of subjects: 300
Study 32534981 — intervention group
Group type: EXPERIMENTAL
Intervention: Resuscitation plan/order present
Number of subjects: 300
Study 32534981 — intervention group
Group type: EXPERIMENTAL
Intervention: Acknowledgment of advance care directive or resuscitation plans/orders in clinical notes
Number of subjects: 300
Study 36303651 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency contraceptive use during the pandemic (March 2020)
Number of subjects: 0
Study 36303651 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergency contraceptive use post-March 2020
Number of subjects: 0
Study 36303651 — intervention group
Group type: COMPARATOR
Intervention: Emergency contraceptive use pre-pandemic
Number of subjects: 0
Study 34273413 — intervention group
Group type: EXPERIMENTAL
Intervention: Odors of different valences (four odors plus odorless air) presented in randomized order
Number of subjects: 62
Study 34273413 — intervention group
Group type: EXPERIMENTAL
Intervention: Odors of different valences
Number of subjects: 62
Study 33980184 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous injection of 0.08 mg/kg oxycodone immediately after completion of the surgical procedure
Number of subjects: 100
Study 33980184 — intervention group
Group type: COMPARATOR
Intervention: Saline injection (Control group)
Number of subjects: 100
Study 35184297 — intervention group
Group type: EXPERIMENTAL
Intervention: CDX-0159 (0.3, 1, 3, and 9 mg/kg)
Number of subjects: 32
Study 35184297 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 34318560 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxia (12% O2)
Number of subjects: 8
Study 34318560 — intervention group
Group type: COMPARATOR
Intervention: Normoxia (21% O2)
Number of subjects: 8
Study 34649747 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyapatite and titanium-coated monoblock shell with an integrated ceramic-on-ceramic bearing (n = 40)
Number of subjects: 86
Study 34649747 — intervention group
Group type: COMPARATOR
Intervention: Porous-coated modular metal-on-polyethylene acetabular component (n = 46)
Number of subjects: 86
Study 33839885 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 802
Study 33839885 — intervention group
Group type: COMPARATOR
Intervention: Unfractionated Heparin (UFH)
Number of subjects: 802
Study 33839885 — intervention group
Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 802
Study 33239632 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal 'Health-conscious' dietary pattern
Number of subjects: 325
Study 36302893 — intervention group
Group type: EXPERIMENTAL
Intervention: HTI vaccines (DNA.HTI, MVA.HTI, ChAdOx1.HTI)
Number of subjects: 45
Study 36302893 — intervention group
Group type: EXPERIMENTAL
Intervention: HTI vaccines
Number of subjects: 45
Study 36302893 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 34336620 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal Shock Wave Therapy (ECSWT) - three sessions, once a week for three weeks
Number of subjects: 40
Study 34336620 — intervention group
Group type: COMPARATOR
Intervention: Phonophoresis therapy - ultrasound using hydrocortisone gel 1% over the trigger point, three times a week for three weeks
Number of subjects: 40
Study 35879422 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart model education set and theoretical expression (Group 2)
Number of subjects: 3
Study 35879422 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart model education set (Group 3)
Number of subjects: 3
Study 35879422 — intervention group
Group type: COMPARATOR
Intervention: Classical education (Group 1)
Number of subjects: 3
Study 35879422 — intervention group
Group type: EXPERIMENTAL
Intervention: Smart model education set (Group 2)
Number of subjects: 3
Study 35879422 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (Group 1, 2, 3)
Number of subjects: 3
Study 35879422 — intervention group
Group type: EXPERIMENTAL
Intervention: Trait anxiety scale (all groups)
Number of subjects: 3
Study 35133995 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-massage and stretching only
Number of subjects: 28
Study 35133995 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-massage and stretching plus gastrocnemius exercise
Number of subjects: 28
Study 36099260 — intervention group
Group type: EXPERIMENTAL
Intervention: tDCS with the anode on primary motor cortex and cathode on the contralateral forehead
Number of subjects: 52
Study 36099260 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 52
Study 33909860 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.23% acidulated phosphate fluoride (APF) gel
Number of subjects: 80
Study 33909860 — intervention group
Group type: COMPARATOR
Intervention: Non-fluoridated gel (control)
Number of subjects: 80
Study 34044625 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based communication between a nurse and a family member for four consecutive days for 10 to 15 minutes
Number of subjects: 67
Study 34044625 — intervention group
Group type: COMPARATOR
Intervention: Control group (no web-based communication)
Number of subjects: 67
Study 33955714 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab monotherapy
Number of subjects: 0
Study 32483058 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotic cognitive therapy
Number of subjects: 173
Study 32483058 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard cognitive therapy
Number of subjects: 173
Study 32483058 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis focused on pain reduction
Number of subjects: 173
Study 32483058 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain education
Number of subjects: 173
Study 32483058 — intervention group
Group type: COMPARATOR
Intervention: All treatments
Number of subjects: 173
Study 35411880 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized Assisted Walking Program (IAWP)
Number of subjects: 307
Study 35411880 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 307
Study 33506388 — intervention group
Group type: EXPERIMENTAL
Intervention: Home telemonitoring group
Number of subjects: 1380
Study 33506388 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1380
Study 32248825 — intervention group
Group type: EXPERIMENTAL
Intervention: EMPOWER‐SUSTAIN intervention for 6 months
Number of subjects: 232
Study 32248825 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 232
Study 32248825 — intervention group
Group type: EXPERIMENTAL
Intervention: EMPOWER‐SUSTAIN intervention
Number of subjects: 232
Study 34529329 — intervention group
Group type: EXPERIMENTAL
Intervention: aPDT + Curcumin
Number of subjects: 63
Study 34529329 — intervention group
Group type: EXPERIMENTAL
Intervention: aPDT + Riboflavin
Number of subjects: 63
Study 34529329 — intervention group
Group type: COMPARATOR
Intervention: 5.25% NaOCl (positive control)
Number of subjects: 63
Study 34529329 — intervention group
Group type: COMPARATOR
Intervention: No intervention (negative control)
Number of subjects: 63
Study 34529329 — intervention group
Group type: EXPERIMENTAL
Intervention: Riboflavin + LED
Number of subjects: 63
Study 34529329 — intervention group
Group type: EXPERIMENTAL
Intervention: Curcumin + LED
Number of subjects: 63
Study 34529329 — intervention group
Group type: EXPERIMENTAL
Intervention: LED
Number of subjects: 63
Study 33053090 — intervention group
Group type: EXPERIMENTAL
Intervention: Dysphagia Risk Evaluation Protocol (DREP) - screening version
Number of subjects: 211
Study 34277384 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal Saline + Triamcinolone Acetonide
Number of subjects: 150
Study 34277384 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal Saline
Number of subjects: 150
Study 34277384 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 150
Study 32248771 — intervention group
Group type: EXPERIMENTAL
Intervention: Alteplase at 0.6 mg/kg
Number of subjects: 131
Study 32248771 — intervention group
Group type: COMPARATOR
Intervention: Standard medical treatment
Number of subjects: 131
Study 34969619 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy (nonverbal and instrumental music in the forms of taqsim, saz semai, and peshrev at speeds of 60 and 100)
Number of subjects: 62
Study 34969619 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 62
Study 34969619 — intervention group
Group type: COMPARATOR
Intervention: Control group (no music therapy)
Number of subjects: 62
Study 32316938 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium citrate 300 mg
Number of subjects: 829
Study 32316938 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 829
Study 35141971 — intervention group
Group type: EXPERIMENTAL
Intervention: Voice treatment (n = 6)
Number of subjects: 19
Study 35141971 — intervention group
Group type: EXPERIMENTAL
Intervention: Articulation treatment (n = 7)
Number of subjects: 19
Study 35141971 — intervention group
Group type: COMPARATOR
Intervention: No treatment (n = 6)
Number of subjects: 19
Study 33197668 — intervention group
Group type: EXPERIMENTAL
Intervention: Six weeks of twice‐weekly Swedish Massage Therapy (SMT)
Number of subjects: 11
Study 33197668 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional six weeks of twice‐weekly Swedish Massage Therapy (SMT)
Number of subjects: 11
Study 33197668 — intervention group
Group type: COMPARATOR
Intervention: Active control (not specified)
Number of subjects: 11
Study 32431023 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatigue Severity Scale (FSS-7) assessment at inclusion, 3 months after stroke, and at follow-up 18 months later
Number of subjects: 145
Study 32431023 — intervention group
Group type: EXPERIMENTAL
Intervention: Time spent walking
Number of subjects: 145
Study 32431023 — intervention group
Group type: EXPERIMENTAL
Intervention: Sedentary behaviour, walking, and sedentary bouts
Number of subjects: 145
Study 35813441 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive care based on appropriate Chinese medicine techniques
Number of subjects: 148
Study 35813441 — intervention group
Group type: COMPARATOR
Intervention: Comprehensive care
Number of subjects: 148
Study 34077684 — intervention group
Group type: EXPERIMENTAL
Intervention: D‐fortified yogurt drink (DY; 1000 IU vitamin D/day)
Number of subjects: 75
Study 34077684 — intervention group
Group type: EXPERIMENTAL
Intervention: Ca‐D‐fortified yogurt drink (CDY; 1000 IU vitamin D plus 500 mg calcium)
Number of subjects: 75
Study 34077684 — intervention group
Group type: COMPARATOR
Intervention: Plain yogurt drink (Control)
Number of subjects: 75
Study 32159395 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediabetics with high plasma ghrelin levels
Number of subjects: 1045
Study 32159395 — intervention group
Group type: EXPERIMENTAL
Intervention: Impaired glucose tolerance (IGT)
Number of subjects: 1045
Study 32159395 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetics
Number of subjects: 1045
Study 32159395 — intervention group
Group type: EXPERIMENTAL
Intervention: Impaired fasting glucose (IFG)
Number of subjects: 1045
Study 32159395 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetics, prediabetics (IFG + IGT), NGT
Number of subjects: 1045
Study 32159395 — intervention group
Group type: EXPERIMENTAL
Intervention: IGT and diabetes groups
Number of subjects: 1045
Study 35255402 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive physiotherapy group (manual interventions, exercise, insoles)
Number of subjects: 39
Study 35255402 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise group (exercise, insoles)
Number of subjects: 39
Study 35255402 — intervention group
Group type: EXPERIMENTAL
Intervention: Insole group (insoles)
Number of subjects: 39
Study 34389250 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower dose of ethambutol (12.5 mg/kg/d)
Number of subjects: 76
Study 34389250 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dose of ethambutol (15.4 mg/kg/d)
Number of subjects: 76
Study 34389250 — intervention group
Group type: COMPARATOR
Intervention: Higher dose of ethambutol
Number of subjects: 76
Study 34389250 — intervention group
Group type: COMPARATOR
Intervention: Lower dose of ethambutol
Number of subjects: 76
Study 34389250 — intervention group
Group type: COMPARATOR
Intervention: Both doses of ethambutol
Number of subjects: 76
Study 34423904 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapastinel 900 mg
Number of subjects: 107
Study 34423904 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapastinel 1800 mg
Number of subjects: 107
Study 34423904 — intervention group
Group type: COMPARATOR
Intervention: Alprazolam 0.75 mg (positive control)
Number of subjects: 107
Study 34423904 — intervention group
Group type: COMPARATOR
Intervention: Ketamine 0.5 mg/kg (clinical comparator)
Number of subjects: 107
Study 34423904 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study 33574564 — intervention group
Group type: EXPERIMENTAL
Intervention: Mapuche women
Number of subjects: 200
Study 33574564 — intervention group
Group type: COMPARATOR
Intervention: Non-Mapuche women
Number of subjects: 200
Study 33574564 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel inflammatory biomarkers
Number of subjects: 200
Study 32664290 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey hydrolysate (WH, n = 9)
Number of subjects: 27
Study 32664290 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey isolate (WI, n = 6)
Number of subjects: 27
Study 32664290 — intervention group
Group type: EXPERIMENTAL
Intervention: Rice and pea combination (RP, n = 6)
Number of subjects: 27
Study 32664290 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL, n = 6)
Number of subjects: 27
Study 32664290 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (WH, WI, RP, PL)
Number of subjects: 27